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The pathogenesis of clinical manifestations caused by newly emerging tick-borne
phleboviruses [i.e., Severe fever with thrombocytopenia syndrome virus (SFTSV) and
Heartland virus (HRTV)], such as severe thrombocytopenia and lymphocytopenia, are
not yet fully understood. In the present study, to establish an animal model mimicking
the profile of fatal human cases, we examined the susceptibilities of adult mice from
12 strains, aged mice from two strains, and cynomolgus macaques to SFTSV and/or
HRTV infections. However, none of these immunocompetent animals developed lethal
diseases after infection with SFTSV or HRTV. Thus, we tested a lethal animal model of
SFTSV infection using interferon- / receptor knock-out (IFNAR−/α β −) mice to identify
the target cell(s) of virus infection, as well as lesions that are potentially associated
with hematological changes. IbaI-positive macrophages and Pax5-positive immature B
cells overlapped with SFTSV-positive cells in the spleen and lymph nodes of IFNAR−/−
mice, and IbaI-SFTSV-double positive cells were also observed in the liver and kidney,
thereby suggesting crucial roles for macrophages in the pathogenesis of SFTSV infection
in mice. In the mandibular lymph nodes and spleens of infected mice, we observed
extensive necrosis comprising B220-positive B cells, which may be associated with
severe lymphocytopenia. The results of this study suggest a resemblance between the
IFNAR−/− mouse model and lethal infections in humans, as well as roles for multiple
cells during pathogenesis in mice.
Keywords: aged mouse, disease modeling, heartland virus, immunocompromised mouse, mouse, nonhuman
primate, severe fever with thrombocytopenia syndrome virus
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INTRODUCTION
Emerging tick-borne pathogens in the genus Phlebovirus in the
family Bunyaviridae, such as Severe fever with thrombocytopenia
syndrome (SFTS) virus (SFTSV) and Heartland virus (HRTV),
cause a severe, often fatal, febrile illness in humans (Yu
et al., 2011; McMullan et al., 2012). SFTS cases have been
identified in East Asian countries [i.e., China, Japan (Takahashi
et al., 2014), and South Korea (Yun et al., 2016)], whereas
HRTV infections have only been reported in the USA
(Stubbs and Steele, 2014). In general, SFTS begins with a
high fever (the fever stage) with marked thrombocytopenia,
leukocytopenia, and a high serum viral load, followed by
the multi-organ dysfunction (MOD) stage, which might be
a consequence of systemic inflammatory response syndrome
and disseminated intravascular coagulation (DIC) (Matsuno
et al., 2014). The serum viral load, which is considered to
be a prognostic marker associated with a fatal outcome (Gai
et al., 2012; Li, 2013), remains high during the MOD stage
but decreases in the convalescent patients. In addition to the
serum viral load, thrombocytopenia is a characteristic of this
disease that determines the fate of patients. However, the
connection(s) between thrombocytopenia/lymphocytopenia and
virus replication is still unclear (Hiraki et al., 2014; Takahashi
et al., 2014).
Developing an animal model of severe/fatal SFTS in humans
is crucial for understanding the pathogenesis of SFTSV
infection and the immune response, which could facilitate the
development of medical countermeasures such as a vaccine
and therapeutics to combat SFTSV. Experimental infection with
SFTSV causes non-fatal mild disease with a moderate decrease in
platelets in immunocompetent laboratory animals (Chen et al.,
2012; Jin et al., 2012, 2015), whereas immunocompromised
interferon α/β receptor-knock-out (IFNAR−/−) mice exhibit
100% lethality after SFTSV infection (Liu et al., 2014). The
IFNAR−/− mouse model has a disadvantage because of
lacking the initial antiviral response in infected animals, but
the lethal IFNAR−/− mouse model is useful for studying
the pathogenesis of severe and fatal forms of SFTS and
also for developing vaccines or antiviral drugs (Tani et al.,
2015). Furthermore, fibroblastic reticular cells have been
identified as the targets of SFTSV infection in the IFNR−/−
mice (Liu et al., 2014), while other cell types, such as
monocytic or blastic cells have been suggested as the targets
of SFTSV infection in humans based on hematological and/or
histopathological studies (Yu et al., 2011; Takahashi et al.,
2014; Peng et al., 2016). The differences and similarities
between the mouse model and human cases should be
studied further for understanding of a crucial step of the
pathogenesis.
In the present study, we first examined the susceptibilities to
SFTSV in 12 different immunocompetent inbred/outbred mouse
strains, aged mice, IFNAR−/− mice, and a nonhuman primate
(cynomolgus macaque) in order to establish an animal model for
SFTS. Finally, we pathologically examined the lethal IFNAR−/−
mouse model to determine its histopathological resemblance to
fatal human SFTS infections.
MATERIALS AND METHODS
Virus and Cells
Severe fever with thrombocytopenia syndrome virus strain
SD4 was provided by the Chinese Center for Disease Control
and Prevention and HRTV strain Mo4 was kindly provided
by the World Reference Center for Emerging Viruses and
Arboviruses (WRCEVA) from the arthropod-borne virus
reference collection at the University of Texas Medical
Branch (UTMB). These strains were propagated in a human
hepatocyte cell line, i.e., human hepatocellular carcinoma
cells (Huh7), for 5 days and the supernatant was centrifuged
twice to remove any debris. The Huh7 cell line was kindly
provided by Dr Yoshiharu Matsuura, Osaka University, and
it was maintained in Dulbecco’s Modified Eagle Medium
supplemented with 2% fetal calf serum, 2 mM L-glutamine,
50 U/ml penicillin, 50 µg/ml streptomycin (Life Technologies),
and 10 µg/ml MycoKill AB (GE Healthcare). The virus
infectivity titers in blood were determined as the median
tissue culture infectious dose (TCID50) detected by using
an indirect immunofluorescent antibody assay with mouse
immune ascitic fluids generated against SFTSV or HRTV, which
were provided by Dr. Robert Tesh, UTMB (Matsuno et al.,
2013).
Animal Study and Sample Collection
Groups of four 6- to 12-week-old mice from inbred strains
(i.e., 129S1/svlmJ, A/J, C57BL/6J, CAST/EiJ, DBA/1J, DBA/2J,
FVB/NJ, NZBWF1/J, and SIL/J), recombinant inbred strains
(i.e., BXD68/RwwJ and BXD34/TyJ), an outbred strain (i.e.,
ICR CD-1) (obtained from Jackson Laboratory), IFNAR−/−
C57BL/6 (breeding pairs kindly provided by Dr. Genhong
Cheng, University of California Los Angeles), and aged (10
to >20 months) 129S1/svlmJ and C57BL/6J strains (obtained
from Jackson Laboratory and kept in-house) were inoculated
with a high dose (105 TCID50/animal) or a low dose
(102 TCID50/animal) of SFTSV SD4 intradermally (i.d.),
intraperitoneally (i.p.), intramuscularly (i.m.), or subcutaneously
(s.c.). The animals were monitored for 14 days after challenge.
Animals that reached the humane endpoint were euthanized and
terminally bled by cardiac puncture. To determine the median
mouse lethal dose (MLD50), groups of four IFNAR−/− C57BL/6
mice were infected with serial 10-fold dilutions of SFTSV SD4
and observed for 2 weeks.
Two groups of two cynomolgus macaques (2 to 3 kg) were
inoculated s.c. with 106 TCID50 of SFTSV SD4 or HRTV Mo4. At
1, 3, 5, 8, 11, and 14 days post inoculation (dpi), blood was drawn
and clinical exams were performed on the anesthetized animals.
Hematology
Hematological parameters were analyzed using EDTA-
treated whole blood with a HemaVet 950FS1 laser-based
hematology analyzer (Drew Scientific). The parameters of
infected IFNAR−/− mice and uninfected mice euthanized were
compared statistically by Mann-Whitney test on GraphPad
Prism v6.0h (GraphPad Software).
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Histopathology and
Immunohistochemistry
Tissues fixed with neutral-buffered formalin (10% v/v) were
processed and embedded in paraffin according to standard
procedures. The embedded tissues were sectioned at 5 µm and
dried overnight at 42◦C before staining with hematoxylin and
eosin. To detect the viral antigen by immunohistochemistry, a
rabbit polyclonal antiserum against SFTSV N protein (kindly
provided by Dr. Shigeru Morikawa, National Institute of
Infectious Diseases, Japan) was used as the primary antibody.
Different types of cells were identified immunohistochemically
as follows: white blood cells [CD45R (B220)], immature B
cells (Pax5), T cells (CD3e), macrophages (IbaI), and reticular
cells (gp36), which were stained with Rat anti-CD45R (BD
Biosciences), Rabbit mAb PAX5 (Cell Signaling), Goat anti-CD3-
ε (Santa Cruz), Rabbit anti-Iba-1 (Wako), and Hamster anti-
Podoplanin (Novusbio), respectively. Each antigen was visualized
with Envision++ system HRP Rabbit (DAKO), Simple stain
AP Rabbit, Simple Stain MAX PO Rat (Nichirei), ImmPress
HRP anti-goat IgG (Vector), or Biotinylated anti-Hamster IgG
(Vector) with SAB-PO (Nichirei) in an appropriate combination
according to the manufacturer’s protocol.
Biosafety Statement
All infectious work with SFTSV or HRTV was performed in a
high containment facility at the Rocky Mountain Laboratories
(RML), Division of Intramural Research (DIR), National Institute
of Allergy and Infectious Diseases (NIAID), National Institutes of
Health (NIH). The work was approved by the RML Institutional
Biosafety Committee (IBC) at biosafety level 3 (BSL3).
Ethics Statement
All of the animal experiments were approved by the Institutional
Animal Care and Use Committee (IACUC) of the RML,
and performed following the guidelines of the Association
for Assessment and Accreditation of Laboratory Animal Care
International (AAALAC) by certified staff in an AAALAC-
approved facility, following the guidelines and basic principles of
the United States Public Health Service Policy on Humane Care
and Use of Laboratory Animals and the Guide for the Care and
Use of Laboratory Animals.
RESULTS
Susceptibility of Various Mouse Strains
and Cynomolgus Macaque to
Human–Pathogenic Tick-Borne
Phlebovirus Infection
In order to compare the susceptibility of various laboratory
mouse strains and different age groups of mice to SFTSV
infection, we inoculated groups of four mice from nine inbred
mouse strains, two recombinant inbred strains, and one outbred
strain with a high dose (105 TCID50/animal) or a low dose
(102 TCID50/animal) of SFTSV SD4, i.d., i.p., i.m., or s.c.
(Table 1). In addition, increased age is a significant risk factor
for the severity of disease in SFTS, especially among those aged
>60 years (Xiong et al., 2012; Ding et al., 2014; Takahashi et al.,
2014), therefore, aged (12–24 months) mouse models based on
two different inbred strains (129S1/svlmJ and C57BL6/J), which
represented humans aged >60 years (Flurkey et al., 2006), were
also infected with SFTSV. None of the mice challenged in this
study developed lethal diseases and no significant lesions were
found in histological examinations of the mice (Table 1). Twelve-
month-old C57BL/6 mice and >20-month-old C57BL/6 mice
infected with SFTSV via s.c. route, led to only moderate weight
loss and all of them survived until 14 dpi.
It has been reported that SFTSV infection causes mild
illness with thrombocytopenia and leukocytopenia in rhesus
macaques. Therefore, in order to investigate whether pathogenic
tick-borne phleboviruses induce visible or severe disease in
cynomolgus macaques, two groups of two macaques were
infected subcutaneously with 106 TCID50 of SFTSV SD4 or
HRTV Mo4. All four macaques infected with SFTSV or HRTV
exhibited no visible clinical signs, except one animal infected with
SFTSV had a temporarily decreased platelet count. Moreover, in
all four of the infected animals, no viruses were detected from
blood during the examination period (at 1, 3, 5, 8, 11, and 14 dpi)
and no macroscopic lesions were found at 14 dpi.
Clinical Disease Signs in IFNAR−/− Mice
that Developed Fatal Illness After SFTSV
Infection
None of the immunocompetent animals tested in this study
developed severe/fatal disease after SFTSV infection, so we
evaluated the sensitivity and lethality of IFNAR−/− mice via
several infection routes and characterized the serum viral load
and hematological status of the mice after SFTSV infection. The
groups of IFNAR−/− mice inoculated with different doses of
SFTSV SD4 via different inoculation routes exhibited severe signs
of clinical disease, such as severe weight loss, ruﬄed fur, and a
hunched posture, and they succumbed to the infection or were
euthanized by 6 dpi (Figure 1). The average time until death
for each group decreased from 6 dpi in the low-dose challenged
groups to 4 dpi in the high-dose challenged groups (Figure 1A).
No significant differences were observed in the survival and
weight curves depending on the route of infection (i.e., i.d.,
i.p., i.m., and s.c.) (Figures 1A,B). The MLD50 for SFTSV
SD4 in IFNAR−/− mice inoculated via s.c. was determined as
8.7 × 10−2 TCID50 (data not shown). The IFNAR−/− mice
euthanized at the endpoint of the fatal illness were subjected
to virological, hematological, and histopathological examinations
in order to investigate the pathogenesis of SFTS in the model.
Whole blood samples from eight mice that reached the humane
endpoint [i.e., three mice from the i.p.-low (mice inoculated
with a low dose of SFTSV via i.p.) group, two mice from the
s.c.-low group, and one mouse each from the i.d., s.c.-high,
and i.m.-low groups] were used in virus titration and those
from six out of the eight mice were used in hematological
examination. Regardless of the route employed, the infected mice
exhibited severe viremia and lymphocytopenia (Figures 1C,D).
The platelet counts (Figure 1E) for the infected mice were
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TABLE 1 | Summary of animal models of human-pathogenic tick-borne phleboviruses.
Virus Animal Strain Outcome/Disease Reference
SFTSV Mouse 129S1/SvlmJ Non-lethal Present study
129S1/SvlmJ (aged 1 yr) Non-lethal Present study
IFNAR−/− 129/Sv Lethal Liu et al., 2014; Shimada et al., 2015
A/J Non-lethal Present study
BALB/c Non-lethal Chen et al., 2012; Jin et al., 2012
BALB/c (newborn) Lethal Chen et al., 2012
BXD34/TyJ Non-lethal Present study
BXD68/RwwJ Non-lethal Present study
C57BL/6 Non-lethal weight loss Chen et al., 2012; Jin et al., 2012, Present study
C57BL/6 (newborn) Lethal Chen et al., 2012
C57BL/6 (aged 1 year) Non-lethal weight loss Present study
C57BL/6 (aged 2 year) Non-lethal weight loss Present study
C57BL/6 (mitomycin C treatment) Lethal Jin et al., 2012
IFNAR−/− C57BL/6 Lethal Tani et al., 2015, Present study
CAST/EiJ Non-lethal Present study
CD-1 Non-lethal Liu et al., 2014, Present study
CD-1 (newborn) Non-lethal Liu et al., 2014
DBA/1J Non-lethal Present study
DBA/2J Non-lethal Present study
FVB/NJ Non-lethal Present study
Kunming Non-lethal Chen et al., 2012
Kunming (newborn) Lethal Chen et al., 2012
NZBWF1/J Non-lethal Present study
SJL/J Non-lethal Present study
Hamster Syrian hamster Non-lethal Jin et al., 2012
Golden hamster Non-lethal Chen et al., 2012; Liu et al., 2014
Golden hamster (newborn) Non-lethal Chen et al., 2012; Liu et al., 2014
Rat Wistar Non-lethal Chen et al., 2012
Wistar (newborn) Non-lethal Chen et al., 2012
Rhesus macaque Non-lethal Jin et al., 2015
Cynomolgus macaque Non-lethal Present study
HRTV Cynomolgus macaque Non-lethal Present study
significantly lower than those of the control animals, and the
mean platelet volumes (Figure 1F) of the infected mice were
significantly higher, thereby suggesting the occurrence of platelet
destruction and the activation of platelet production.
Pathological and Histopathological
Observations of IFNAR−/− Mice Infected
with SFTSV
Loss of splenic white pulp and diffuse reticuloendothelial
hyperplasia of the red pulp were evident in the spleens of
infected mice (Figure 2A). Destruction of lymphoid follicles
was observed in the cortex of the cervical lymph nodes as well.
The SFTSV-infected mice developed histiocytic and necrotizing
lymphadenitis lesions with pyknosis and karyorrhexis of
lymphocytes in the spleen and cervical lymph nodes at the
terminal stage of infection (Figure 2A, magnified figures).
The subcapsular and medullary sinuses frequently contained
moderate amounts of edema and fibrin with thrombosis of
multiple vessels within the nodes, and histiocytic proliferation
was observed in both the medulla and cortex of the affected
lymph nodes. In the bone marrow, there was a paucity of
erythroid precursor cells and an increase in the myeloid to
erythroid ratio (Figure 2B). Minimal to moderate necrosis of the
bone marrow was collocated with edema and fibrin (Figure 2B,
magnified figure). B220-positive B cells in the spleen and
lymph nodes of the infected mice were apparently decreased in
number and distributed in the disrupted structure of each tissue
(Figure 2C). Furthermore, increased numbers of IbaI-positive
cells with enlarged cytoplasm, which might have been Kupfer
cells, were observed in the livers of infected mice compared with
those in the uninfected mice (Figure 2D).
Target Cells of SFTSV Infection in the
Lethal IFNAR−/− Mouse Model
Severe fever with thrombocytopenia syndrome virus antigen-
positive cells were found in the spleen, lymph nodes, liver, and
kidney (Figure 3), whereas they were not observed in the spinal
cord, gastrointestinal tract, brain, and heart (data not shown).
The antigen-positive cells were most abundant in the spleen
among the tissues examined. Several antigen-positive cells were
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FIGURE 1 | Clinical manifestations in IFNAR−/− mice infected with SFTSV. Groups of four IFNAR−/− mice were infected with a high dose (105
TCID50/mouse) or low dose (102 TCID50/mouse) of the SFTSV strain SD4, intradermally (i.d.), intraperitoneally (i.p.), intramuscularly (i.m.), or subcutaneously (s.c.).
The mice were monitored daily to assess survival (A) and body weight (B) and results until 6 days post inoculation (dpi) were shown. The blood from the infected
mice euthanized because they reached the humane endpoint and the uninfected mice euthanized at 6 dpi were subjected to virus titration (C) and hematological
examinations, i.e., lymphocyte count (D), platelet count (E), and mean platelet volume (F). All values are indicated as means ± SD. ∗P < 0.05, compared with
uninfected controls.
morphologically classified into three different cell types (i.e.,
monocytes, lymphocytes, and reticular cells, magnified figures
in Figure 3), which were distributed diffusely in the spleen and
lymph nodes. However, the necrotic cells in the lesions were
rarely positive for the SFTSV antigen. Monocyte-like antigen-
positive cells were frequently found surrounding the necrotic
lesions in the spleen and lymph nodes. Monocyte-like antigen-
positive cells were also observed in the liver but without obvious
pathological changes, although the prevalence of the infected cells
was clearly lower than that in the spleen and lymph nodes. The
interstitial cells of the renal cortex in the kidney were positive for
SFTSV antigen. The infected cells in the kidney were distributed
sporadically throughout the tissue and they accumulated in the
renal capsules and proximal tubules.
In order to identify the cells in which the virus replicates,
double immunohistochemical staining of the host cell marker(s)
and virus antigens was performed using tissues from the spleen,
cervical lymph nodes, liver, and kidney (Figure 4). In the spleen,
the majority of the SFTSV-infected cells overlapped with the
IbaI-positive macrophages or gp36-positive reticular cells and
none or a few overlapped with the CD3e- or Pax5-positive T
or immature B lymphocytes (Figure 4A). Phagocytosis of the
SFTSV-infected lymphocytes by IbaI-positive macrophages was
detected (Figure 4A, arrow). IbaI-positive macrophages infected
with SFTSV were dispersed throughout the organ. However,
while the SFTSV/IbaI double positive cells were major among the
SFTSV-infected cells, most of the macrophages in the spleen were
not infected with the virus. A limited number of Pax5-positive
B cells were found in the same lesions where extensive necrosis
of B220-positive B cells (which may have included Pax5-positive
cells) was observed in the spleen. Similar overlapping of the
SFTSV antigens with IbaI, Pax5, and gp36 was also found in the
lymph nodes (Figure 4B). There was a high level of overlapping
for IbaI and SFTSV antigens in the liver (Figure 4C) and kidney
(Figure 4D). A few interstitial gp36-positive reticular cells in the
kidney were infected with SFTSV. Our results demonstrate that
macrophages, immature B cells, and reticular cells were infected
with SFTSV in the terminal stage of the IFNAR−/−mouse model.
DISCUSSION
At present, only type I IFN-deficient mouse models [(Liu et al.,
2014; Tani et al., 2015), and the present study], newborn mice
(Chen et al., 2012), and mitomycin-treated mice (Jin et al., 2012)
are available as models for the fatal illness caused by SFTSV
infection. Immunocompetent mice [except newborn mice (Chen
et al., 2012)], hamsters (Chen et al., 2012; Jin et al., 2012),
and macaques (Jin et al., 2015) exhibit moderate disease or
are asymptomatic. Therefore, we performed screening of mouse
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FIGURE 2 | Histopathological observations of tissues of the IFNAR−/− mice infected with SFTSV. The spleen, lymph nodes, bone marrow, and livers of
SFTSV-infected and uninfected mice were used for histopathologic observations. Losses of the structure with massive apoptosis were observed in hematoxylin and
eosin-stained tissues (A); Magnified images of pyknosis and karyorrhexis observed in the necrotic lesions are indicated at the top right corner of the infected spleen
and lymph node. The increased myeloid/erythroid ratio in the bone marrow of infected mice was observed (B); A magnified image of moderate necrosis collocating
with edema and fibrin is shown at the top right corner. Colocalization of B220-positive cells with necrotic lesions in the spleen and lymph node (C) as well as
IbaI-positive cells with enlarged cytoplasm in the liver (D) were visualized by immunohistochemistry.
strains with different genetic backgrounds, which contributed
to establish a lethal model of monkeypox virus infection
(Americo et al., 2010), but none of the immunocompetent
mice developed fatal disease with SFTSV infection (Table 1).
Among the mice challenged in the present study, the two-year-
old C57BL/6 mice only exhibited weight loss of not more than
10%, whereas the young mice did not exhibit any weight losses.
Thus, factors associated with aging (such as immunological
disorders and hematological dysfunctions) may be required to
recapitulate the fatal outcome in the mouse model. Several
aged mice are usually unavailable for routine investigations,
so employing senescence accelerated mice may facilitate the
investigation of factors affected by aging over relatively short
periods (Vanhooren and Libert, 2013), and this approach should
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FIGURE 3 | SFTSV infection in tissues from IFNAR−/− mice infected with SFTSV. The spleen (A), lymph node (B), liver (C), and kidney (D) of SFTSV-infected
mice were stained with antibodies raised against SFTSV N antigen. Antigen-positive monocyte-like cells (magnified images at the top), lymphocyte-like cells (middle),
and reticular cells (bottom) were morphologically identified in the sample tissues.
be considered for examining the effects of aging on the fatal
outcome.
The present study clearly demonstrated that the IFNAR−/−
mouse model recapitulated fatal diseases with hematologic
manifestations similar to human cases (i.e., lymphocytopenia and
thrombocytopenia). Similar to previous studies with IFNAR−/−
(Table 2), extensive necrosis and histiocytic proliferation in
the lymph nodes were confirmed as the characteristic common
histopathological observations in both fatal human cases (Hiraki
et al., 2014; Takahashi et al., 2014) and the IFNAR−/− mouse
model (Tani et al., 2015). The replication site of SFTSV in
the terminal stage of infection was also the lymph nodes in
humans and mice. However, hemophagocytosis in the lymph
nodes, bone marrow, and spleen, which is a characteristic lesion
in fatal human cases, was not observed in our IFNAR−/−
mice. In addition, the complete loss of splenic white pulp
might be a specific lesion in IFNAR−/− mice. These differences
between the mouse model and human cases as well as their
genetic background should be considered carefully to explain the
pathogenesis of SFTSV infection in mice, especially to discuss the
suitability of the model in antiviral or vaccine studies.
The structures of the splenic white pulp and follicles in
lymph nodes mainly comprised B cells, so the severe necrotizing
lymphadenitis associated with the lesions was probably related
to the significant decreases in the white blood cell counts.
Furthermore, among the B220-positive B cells in the necrotic
lesions, Pax5-positive immature B cells were identified as targets
of SFTSV infection. Our results suggest that the immature B
cells were: (1) first affected by virus infection in the spleen
and lymph nodes, and they then produced cytokines that
led to extensive apoptosis and lymphocytopenia; and/or (2)
more susceptible to SFTSV infection than the other B cells
that remained SFTSV antigen-positive until the terminal stage.
The monocytic proliferations near the lesions with massive
apoptosis and phagocytosis in the infected cells were antiviral
responses by peripheral monocytes that participated in the initial
inflammatory response (Serbina et al., 2008), which may also be
important for the progression of lymphocyte apoptosis.
Interestingly, the activation of uninfected macrophages was
observed throughout the liver, where the infected cells were not
detected frequently, in contrast to the case in the spleen or
lymph nodes. These macrophages in the liver mainly comprised
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FIGURE 4 | Colocalization of host cell markers and SFTSV antigen in SFTSV-infected tissues from IFNAR−/− mice. The spleen (A) lymph node (B), liver
(C), and kidney (D) of the SFTSV-infected mice were subjected to double staining with anti-SFTSV N antibodies and host cellular markers: CD3e (T cells), IbaI
(macrophages), Pax5 (immature B cells), and gp36 (reticular cells). Cells stained with both SFTSV and host cellular markers are indicated by arrowheads, and the
phagocytosis of an infected cell by an IbaI-positive macrophage is indicated by an arrow.
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TABLE 2 | Comparison of histopathological characteristics of SFTSV models and patients.
Model Time to
death
Lymph node Spleen Bone marrow Liver Kidney Reference
C57BL/6
IFNAR−/−
5–7 days Histiocytic
necrotizing
lymphadenitis
Histiocytic
necrotizing
lymphadenitis
Increasing the
myeloid/erythroid
ratio
Diffuse infiltration by
inflammatory cells
Antigen-positive
large mononuclear
cells
Tani et al., 2015,
Present study
Loss of lymphoid
follicles in the
cortex
Loss of white pulp Moderate necrosis
collocating with
edema and fibrin
Focal necrosis with
slight inflammatory
cell infiltration
Antigen-positive
swollen Kupffer
cells
129/Sv
IFNAR−/−
2–3 days Antigen-positive
mononuclear cells
Not significant Liu et al., 2014;
Shimada et al.,
2015; Hayasaka
et al., 2016
C57BL/6 – Marked increase in
megakaryocytes
Significantly
increased
megakaryocytes
Ballooning
degeneration of
hepatocytes
Glomerular
hypercellularity
Jin et al., 2012; Liu
et al., 2014
Decreased
lymphocyte
cellularity in the red
pulp
Scattered necrosis Mesangial
thickening
Multifocal pyknosis,
karyorrhexis, and
karyokysis
Congestion in
Bowman’s space
Newborn 7–13 days Large necrotic
areas
Chen et al., 2012
Large amount of
mononuclear cells
Rhesus
macaque
– Multiple scattered
loci with hepatocyte
necrosis
Glomerular
hypercellularity
Jin et al., 2015
Mesangial
thickening
Congestion in
Bowman’s space
Human
(fatalities)
Necrotizing
lymphadenitis with
extensive necrosis
Prominent
hemophagocytosis
Prominent
hemophagocytosis
Mild microvesicular
fatty changes
Subepithelial
hemorrhage within
the renal pelvis
Hiraki et al., 2014;
Takahashi et al.,
2014; Kim et al.,
2016
Infitration by
histiocytes and
immunoblasts
Histiocytic
hypocellular
Inflammation of
lymphocytes and
macrophages
Prominent
hemophagocytosis
Globular necroses
and mild portal
fibrosis
Kupffer cells (Tani et al., 2015), and thus the activation of
hepatic macrophages could be a normal response to the platelets
activated by the binding of SFTSV virions (Jin et al., 2012), or
a response to infected monocytes permeating from the blood
stream. Hepatocytes were not infected with SFTSV in mouse
models, but moderate hepatocellular hypertrophy has been found
in some IFNAR−/− mice (data not shown) according to a
previous report (Liu et al., 2014), which suggests that the
cytokines/chemokines produced from the virus-infected Kupffer
cells might affect the hepatocytes (Boltjes et al., 2014). In the
previous immunocompetent mouse model, proinflammatory
cytokines, and chemokines were produced from the liver in
SFTSV-infected mice (Sun et al., 2015). In addition, elevated
aminotransferases (i.e., AST and ALT) were reported frequently
in SFTS patients, even in the recovered cases (Xu et al., 2011;
Yu et al., 2011; Sun et al., 2012), thereby indicating that hepatic
damage is a common clinical manifestation in humans and
currently available animal models. Therefore, Kupffer cells may
play a central role in hepatic damage by producing cytokines
and chemokines, as well as in thrombocytopenia during SFTSV
infection, but the mechanism(s) responsible for Kupffer cell
activation remains unclear.
Our histopathological examinations of the mouse model
determined the contributions of multiple cell types to
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pathogenesis in the lethal SFTSV infection as well as the
target cells of the virus infection in mice. We demonstrated
that this model should be suitable for antiviral drug screening
(Tani et al., 2015), or for other purposes that do not require
complete immune systems. There were pathological differences
between the present study and two previous studies (Liu
et al., 2014; Tani et al., 2015) that used IFNAR−/− mice,
which were due to the different genetic backgrounds of the
mice [129/Sv (Liu et al., 2014) and C57BL/6 (Tani et al.,
2015) and the present study)] and/or virus strains [HB29 (Liu
et al., 2014), SPL010 (Tani et al., 2015), and SD4 in the
present study], as well as the antigen/antibody combinations
used for the cellular markers. These differences should be
addressed in future research to understand the pathogenesis of
SFTS.
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